Literature DB >> 23528638

Outbreak of Citrobacter freundii carrying VIM-1 in an Italian Hospital, identified during the carbapenemases screening actions, June 2012.

Paolo Gaibani1, Simone Ambretti, Patrizia Farruggia, Gloria Bua, Andrea Berlingeri, Maria Vittoria Tamburini, Miriam Cordovana, Luca Guerra, Magda Mazzetti, Greta Roncarati, Ciro Tenace, Maria Luisa Moro, Carlo Gagliotti, Maria Paola Landini, Vittorio Sambri.   

Abstract

OBJECTIVE: The identification of patients colonized or infected with carbapenemase-producing Enterobacteriaceae (CPE), in order to control and prevent the global spread of multidrug-resistant (MDR) pathogens.
METHODS: From June 1 to June 15, 2012, eight Citrobacter freundii strains with reduced susceptibility to carbapenems were isolated from rectal swabs of hospitalized patients during active screening following the detection of a Klebsiella pneumoniae carbapenemase (KPC) -positive patient on the ward. All isolates were analyzed phenotypically and molecularly by PCR and sequencing. Genotype clustering was performed by multilocus sequence typing (MLST) analysis.
RESULTS: The isolates showed high rates of multidrug resistance profile. A phenotypic assay for carbapenemase production suggested the presence of metallo-β-lactamase (MBL). The blaVIM-1 gene was detected in all imipenem-resistant C. freundii isolates. MLST showed that the C. freundii isolates shared the same sequence type (ST). Phylogenetic analysis revealed a strict relationship with an ST5C. freundii isolate from a diarrhea patient in China.
CONCLUSIONS: Our findings showed that the active surveillance program for CPE was useful, not only for the detection of KPC-producers, but also to identify and control the spread of other MDR pathogens that could expand the spectrum of circulating MDR pathogens.
Copyright © 2013 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Citrobacter freundii; Italy; MLST; VIM-1

Mesh:

Substances:

Year:  2013        PMID: 23528638     DOI: 10.1016/j.ijid.2013.02.007

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  12 in total

1.  Interplay among IncA and bla KPC-Carrying Plasmids in Citrobacter freundii.

Authors:  Ibrahim Bitar; Mariasofia Caltagirone; Laura Villa; Vittoria Mattioni Marchetti; Elisabetta Nucleo; Mario Sarti; Roberta Migliavacca; Alessandra Carattoli
Journal:  Antimicrob Agents Chemother       Date:  2019-04-25       Impact factor: 5.191

2.  KPC-Like Carbapenemase-Producing Enterobacteriaceae Colonizing Patients in Europe and Israel.

Authors:  A Baraniak; R Izdebski; J Fiett; M Herda; L P G Derde; M J M Bonten; A Adler; Y Carmeli; H Goossens; W Hryniewicz; C Brun-Buisson; M Gniadkowski
Journal:  Antimicrob Agents Chemother       Date:  2015-12-28       Impact factor: 5.191

3.  A Systematic Review and Meta-analyses of the Clinical Epidemiology of Carbapenem-Resistant Enterobacteriaceae.

Authors:  Karlijn van Loon; Anne F Voor In 't Holt; Margreet C Vos
Journal:  Antimicrob Agents Chemother       Date:  2017-12-21       Impact factor: 5.191

4.  Genomic epidemiology of global VIM-producing Enterobacteriaceae.

Authors:  Yasufumi Matsumura; Gisele Peirano; Rebekah Devinney; Patricia A Bradford; Mary R Motyl; Mark D Adams; Liang Chen; Barry Kreiswirth; Johann D D Pitout
Journal:  J Antimicrob Chemother       Date:  2017-08-01       Impact factor: 5.790

5.  Emergence of Citrobacter freundii carrying IMP-8 metallo-β-lactamase in Germany.

Authors:  S Peter; C Wolz; M Kaase; M Marschal; B Schulte; W Vogel; I Autenrieth; M Willmann
Journal:  New Microbes New Infect       Date:  2014-03-20

6.  The human jejunum has an endogenous microbiota that differs from those in the oral cavity and colon.

Authors:  Olof H Sundin; Antonio Mendoza-Ladd; Mingtao Zeng; Diana Diaz-Arévalo; Elisa Morales; B Matthew Fagan; Javier Ordoñez; Philip Velez; Nishaal Antony; Richard W McCallum
Journal:  BMC Microbiol       Date:  2017-07-17       Impact factor: 3.605

7.  Clinical and Genomic Epidemiology of Carbapenem-Nonsusceptible Citrobacter spp. at a Tertiary Health Care Center over 2 Decades.

Authors:  Ahmed Babiker; Daniel R Evans; Marissa P Griffith; Christi L McElheny; Mohamed Hassan; Lloyd G Clarke; Roberta T Mettus; Lee H Harrison; Yohei Doi; Ryan K Shields; Daria Van Tyne
Journal:  J Clin Microbiol       Date:  2020-08-24       Impact factor: 5.948

8.  Development of rapid and simple experimental and in silico serotyping systems for Citrobacter.

Authors:  Chengqian Qian; Yuhui Du; Huiying Li; Pan Wu; Lu Wang; Yi Wei; Hengchun Cao; Zhiqiu Yin; Yang Zhang; Yiming Zhu; Xi Guo; Bin Liu
Journal:  Future Microbiol       Date:  2018-08-13       Impact factor: 3.165

Review 9.  Screening for carriage of carbapenem-resistant Enterobacteriaceae in settings of high endemicity: a position paper from an Italian working group on CRE infections.

Authors:  Simone Ambretti; Matteo Bassetti; Pierangelo Clerici; Nicola Petrosillo; Fabio Tumietto; Pierluigi Viale; Gian Maria Rossolini
Journal:  Antimicrob Resist Infect Control       Date:  2019-08-13       Impact factor: 4.887

10.  First Italian outbreak of VIM-producing Serratia marcescens in an adult polyvalent intensive care unit, August-October 2018: A case report and literature review.

Authors:  Maria Rosaria Iovene; Vincenzo Pota; Massimiliano Galdiero; Giusy Corvino; Federica Maria Di Lella; Debora Stelitano; Maria Beatrice Passavanti; Maria Caterina Pace; Aniello Alfieri; Sveva Di Franco; Caterina Aurilio; Pasquale Sansone; Vettakkara Kandy Muhammed Niyas; Marco Fiore
Journal:  World J Clin Cases       Date:  2019-11-06       Impact factor: 1.337

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.